Efficacy of gemfibrozil in the primary prevention of atrial fibrillation in a large randomized controlled trial.
第一作者:
A Selcuk,Adabag
第一单位:
Division of Cardiology, Center for Chronic Disease Outcomes Research, Veterans Affairs Medical Center, Minneapolis, MN, USA. adaba001@umn.edu
作者:
主题词
老年人(Aged);心房颤动(Atrial Fibrillation);胆固醇, HDL(Cholesterol, HDL);胆固醇, LDL(Cholesterol, LDL);冠心病(Coronary Disease);双盲法(Double-Blind Method);心电描记术(Electrocardiography);女(雌)性(Female);随访研究(Follow-Up Studies);吉非贝齐(Gemfibrozil);人类(Humans);降血脂药物(Hypolipidemic Agents);男(雄)性(Male);中年人(Middle Aged);氧化性应激(Oxidative Stress);一级预防(Primary Prevention);回顾性研究(Retrospective Studies);危险因素(Risk Factors);时间因素(Time Factors);治疗结果(Treatment Outcome)
DOI
10.1016/j.ahj.2009.02.015
PMID
19376321
发布时间
2013-11-21
- 浏览10
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文